Literature DB >> 18462943

Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.

Anneli Nordqvist1, Mikael T Nilsson, Svenja Röttger, Luke R Odell, Wojciech W Krajewski, C Evalena Andersson, Mats Larhed, Sherry L Mowbray, Anders Karlén.   

Abstract

A combination of a literature survey, structure-based virtual screening and synthesis of a small library was performed to identify hits to the potential antimycobacterial drug target, glutamine synthetase. The best inhibitor identified from the literature survey was (2S,5R)-2,6-diamino-5-hydroxyhexanoic acid (4, IC(50) of 610+/-15microM). In the virtual screening 46,400 compounds were docked and subjected to a pharmacophore search. Of these compounds, 29 were purchased and tested in a biological assay, allowing three novel inhibitors containing an aromatic scaffold to be identified. Based on one of the hits from the virtual screening a small library of 15 analogues was synthesized producing four compounds that inhibited glutamine synthetase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462943     DOI: 10.1016/j.bmc.2008.04.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

Review 1.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

2.  Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors.

Authors:  Johan Gising; Mikael T Nilsson; Luke R Odell; Samir Yahiaoui; Martin Lindh; Harini Iyer; Achyut M Sinha; Bachally R Srinivasa; Mats Larhed; Sherry L Mowbray; Anders Karlén
Journal:  J Med Chem       Date:  2012-03-08       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.